Anthrax vaccine candidate, NuThrax, moves forward in development
by Press Release from Outbreak News Today on (#1WJJ4)
An anthrax vaccine that may be effective in as few as two doses is moving forward in development with the assistance of the U.S. Department of Health and Human Services' (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The five-year, $198.7 million contract between ASPR's Biomedical Advanced Research and Development Authority (BARDA) ["]
